Generate Biomedicines, Inc. (GENB)
NASDAQ: GENB · Real-Time Price · USD
11.51
+0.07 (0.61%)
At close: Mar 30, 2026, 4:00 PM EDT
11.51
0.00 (0.00%)
After-hours: Mar 30, 2026, 7:12 PM EDT
Generate Biomedicines Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$25.00
Upside
+117.20%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $26 | Strong Buy | Initiates | $26 | +125.89% | Mar 24, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $20 | Buy | Initiates | $20 | +73.76% | Mar 24, 2026 |
| Piper Sandler | Piper Sandler | Buy Initiates $24 | Buy | Initiates | $24 | +108.51% | Mar 24, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 24, 2026 |
| Guggenheim | Guggenheim | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +160.64% | Mar 24, 2026 |